Spyre Therapeutics Inc (NAS:SYRE)
$ 36.47 2.82 (8.38%) Market Cap: 1.85 Bil Enterprise Value: 1.56 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 43/100

Spyre Therapeutics Inc (SYRE) Transcripts

  • 1